Work

Glycoproteomics as a powerful liquid biopsy-based predictor of checkpoint inhibitor treatment benefit in metastatic malignant melanoma.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.9545

Authors: Klaus Lindpaintner, Alan Mitchell, Chad Pickering, Gege Xu, Kimberly Vigal, Bianca Axenfeld, Rachel Rice, Xin Cong, Dennie T. Frederick, William Michaud, Genevieve Marie Boland, Danie Serie

Institution: Massachusetts General Hospital

Language: English

Topic: Glycosylation and Glycoproteins Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4282015982

Cites:

Cited by: 5

Related to: 10